Literature DB >> 20234126

Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease.

Roberto P Benzo1, Chung-Chou H Chang, Max H Farrell, Robert Kaplan, Andrew Ries, Fernando J Martinez, Robert Wise, Barry Make, Frank Sciurba.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a leading cause of death and 70% of the cost of COPD is due to hospitalizations. Self-reported daily physical activity and health status have been reported as predictors of a hospitalization in COPD but are not routinely assessed.
OBJECTIVES: We tested the hypothesis that self-reported daily physical activity and health status assessed by a simple question were predictors of a hospitalization in a well-characterized cohort of patients with severe emphysema.
METHODS: Investigators gathered daily physical activity and health status data assessed by a simple question in 597 patients with severe emphysema and tested the association of those patient-reported outcomes to the occurrence of a hospitalization in the following year. Multiple logistic regression analyses were used to determine predictors of hospitalization during the first 12 months after randomization.
RESULTS: The two variables tested in the hypothesis were significant predictors of a hospitalization after adjusting for all univariable significant predictors: >2 h of physical activity per week had a protective effect [odds ratio (OR) 0.60; 95% confidence interval (95% CI) 0.41-0.88] and self-reported health status as fair or poor had a deleterious effect (OR 1.57; 95% CI 1.10-2.23). In addition, two other variables became significant in the multivariate model: total lung capacity (every 10% increase) had a protective effect (OR 0.88; 95% CI 0.78-0.99) and self-reported anxiety had a deleterious effect (OR 1.75; 95% CI 1.13-2.70).
CONCLUSION: Self-reported daily physical activity and health status are independently associated with COPD hospitalizations. Our findings, assessed by simple questions, suggest the value of patient-reported outcomes in developing risk assessment tools that are easy to use.

Entities:  

Mesh:

Year:  2010        PMID: 20234126      PMCID: PMC2889264          DOI: 10.1159/000296504

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  31 in total

1.  Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease.

Authors:  Pedro Almagro; Bienvenido Barreiro; Anna Ochoa de Echaguen; Salvador Quintana; Mónica Rodríguez Carballeira; José L Heredia; Javier Garau
Journal:  Respiration       Date:  2005-09-06       Impact factor: 3.580

2.  Integrated tobacco cessation counseling in a diabetes self-management training program: a randomized trial of diabetes and reduction of tobacco.

Authors:  Jennifer M Hokanson; Robyn L Anderson; Deborah J Hennrikus; Harry A Lando; David M Kendall
Journal:  Diabetes Educ       Date:  2006 Jul-Aug       Impact factor: 2.140

3.  An inventory for measuring clinical anxiety: psychometric properties.

Authors:  A T Beck; N Epstein; G Brown; R A Steer
Journal:  J Consult Clin Psychol       Date:  1988-12

4.  Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression.

Authors:  G Gudmundsson; T Gislason; C Janson; E Lindberg; R Hallin; C S Ulrik; E Brøndum; M M Nieminen; T Aine; P Bakke
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

5.  Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group.

Authors:  Keith S Naunheim; Douglas E Wood; Zab Mohsenifar; Alice L Sternberg; Gerard J Criner; Malcolm M DeCamp; Claude C Deschamps; Fernando J Martinez; Frank C Sciurba; James Tonascia; Alfred P Fishman
Journal:  Ann Thorac Surg       Date:  2006-08       Impact factor: 4.330

6.  Trends in the leading causes of death in the United States, 1970-2002.

Authors:  Ahmedin Jemal; Elizabeth Ward; Yongping Hao; Michael Thun
Journal:  JAMA       Date:  2005-09-14       Impact factor: 56.272

7.  A multidimensional grading system (BODE index) as predictor of hospitalization for COPD.

Authors:  Kian-Chung Ong; Arul Earnest; Suat-Jin Lu
Journal:  Chest       Date:  2005-12       Impact factor: 9.410

8.  Integrated care prevents hospitalisations for exacerbations in COPD patients.

Authors:  A Casas; T Troosters; J Garcia-Aymerich; J Roca; C Hernández; A Alonso; F del Pozo; P de Toledo; J M Antó; R Rodríguez-Roisín; M Decramer
Journal:  Eur Respir J       Date:  2006-04-12       Impact factor: 16.671

9.  Predicting mortality and healthcare utilization with a single question.

Authors:  Karen B DeSalvo; Vincent S Fan; Mary B McDonell; Stephan D Fihn
Journal:  Health Serv Res       Date:  2005-08       Impact factor: 3.402

10.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

Authors:  Bartolome R Celli; Claudia G Cote; Jose M Marin; Ciro Casanova; Maria Montes de Oca; Reina A Mendez; Victor Pinto Plata; Howard J Cabral
Journal:  N Engl J Med       Date:  2004-03-04       Impact factor: 91.245

View more
  27 in total

1.  Development and feasibility of a self-management intervention for chronic obstructive pulmonary disease delivered with motivational interviewing strategies.

Authors:  Roberto Benzo; Kristin Vickers; Denise Ernst; Sharon Tucker; Charlene McEvoy; Kate Lorig
Journal:  J Cardiopulm Rehabil Prev       Date:  2013 Mar-Apr       Impact factor: 2.081

2.  Feasibility and acceptability of active for life with COPD, an intervention to increase light physical activity in people with COPD.

Authors:  Janet L Larson; Katelyn E Webster
Journal:  Heart Lung       Date:  2020-01-31       Impact factor: 2.210

3.  The role of physical inactivity in increasing disability among older adults with obstructive airway disease.

Authors:  Patricia Katz; Hubert Chen; Theodore A Omachi; Steven E Gregorich; Laura Julian; Miriam Cisternas; John Balmes; Paul D Blanc
Journal:  J Cardiopulm Rehabil Prev       Date:  2011 May-Jun       Impact factor: 2.081

4.  Physical Activity Behaviour in People with COPD Residing in Spain: A Cross-Sectional Analysis.

Authors:  Sheila Sánchez Castillo; Lee Smith; Arturo Díaz Suárez; Guillermo Felipe López Sánchez
Journal:  Lung       Date:  2019-11-04       Impact factor: 2.584

5.  Fitness memberships and favorable selection in Medicare Advantage plans.

Authors:  Alicia L Cooper; Amal N Trivedi
Journal:  N Engl J Med       Date:  2012-01-12       Impact factor: 91.245

Review 6.  Lung volume reduction surgery: nonpharmacological approach.

Authors:  Roberto Benzo
Journal:  Curr Opin Anaesthesiol       Date:  2011-02       Impact factor: 2.706

7.  The impact of low forced vital capacity on behavior restrictions in a population with airflow obstruction.

Authors:  Noeul Kang; Sun Hye Shin; Seonhye Gu; Danbee Kang; Juhee Cho; Ho Jung Jeong; Gee Young Suh; Hyun Lee; Hye Yun Park
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

8.  Factors to inform clinicians about the end of life in severe chronic obstructive pulmonary disease.

Authors:  Roberto Benzo; Wendy Siemion; Paul Novotny; Alice Sternberg; Robert M Kaplan; Andrew Ries; Robert Wise; Fernando Martinez; James Utz; Frank Sciurba
Journal:  J Pain Symptom Manage       Date:  2013-03-21       Impact factor: 3.612

9.  Physical activity in people with COPD, using the National Health and Nutrition Evaluation Survey dataset (2003-2006).

Authors:  Soo Kyung Park; Caroline R Richardson; Robert G Holleman; Janet L Larson
Journal:  Heart Lung       Date:  2013-05-29       Impact factor: 2.210

10.  Disability and recovery of independent function in obstructive lung disease: the cardiovascular health study.

Authors:  Vincent S Fan; Emily R Locke; Paula Diehr; Anthony Wilsdon; Paul Enright; Sachin Yende; Mark Avdalovic; Graham Barr; Vishesh K Kapur; Rachel Thomas; Jerry A Krishnan; Gina Lovasi; Stephen Thielke
Journal:  Respiration       Date:  2014-09-09       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.